FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2790869523> ?p ?o ?g. }

• W2790869523 endingPage "1582" @default.
• W2790869523 startingPage "1575" @default.
• W2790869523 abstract "Objectives We aimed to analyse outcomes of ticagrelor and clopidogrel stratified by estimated glomerular filtration rate (eGFR) in a large unselected cohort of patients with acute myocardial infarction (MI). Methods We used follow-up data in MI survivors discharged on ticagrelor or clopidogrel enrolled in the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies registry. The association between ticagrelor versus clopidogrel and the primary composite outcome of death, MI or stroke and the secondary outcome rehospitalisation with bleeding diagnosis at 1 year, was studied using adjusted Cox proportional hazards models, stratifying after eGFR levels. Results In total, 45 206 patients with MI discharged on clopidogrel (n=33 472) or ticagrelor (n=11 734) were included. The unadjusted 1-year event rate for the composite endpoint of death, MI or stroke was 7.0%, 18.0% and 48.0% for ticagrelor treatment and 11.0%, 33.0% and 64.0% for clopidogrel treatment in patients with eGFR >60 (n=33 668), eGFR 30–60 (n=9803) and eGFR <30 (n=1735), respectively. After adjustment, ticagrelor as compared with clopidogrel was associated with a lower 1-year risk of the composite outcome (eGFR >60 : HR 0.87, 95% CI 0.76 to 99, eGFR 30–60 : 0.82 (0.70 to 0.97), eGFR <30 : 0.95 (0.69 to 1.29), P for interaction=0.55) and a higher risk of bleeding (eGFR >60 : HR 1.10, 95% CI 0.90 to 1.35, eGFR 30–60 : 1.13 (0.84 to 1.51), eGFR <30 : 1.79 (1.00 to 3.21), P for interaction=0.30) across the eGFR strata. Conclusions Treatment with ticagrelor as compared with clopidogrel in patients with MI was associated with lower risk for the composite of death, MI or stroke and a higher bleeding risk across all strata of eGFR. Of caution, bleeding events were more abundant in patients with eGFR <30 ." @default.
• W2790869523 created "2018-03-29" @default.
• W2790869523 creator A5000473191 @default.
• W2790869523 creator A5004123368 @default.
• W2790869523 creator A5040457003 @default.
• W2790869523 creator A5043946749 @default.
• W2790869523 creator A5047500450 @default.
• W2790869523 creator A5051109511 @default.
• W2790869523 creator A5073269975 @default.
• W2790869523 creator A5073596004 @default.
• W2790869523 creator A5074948512 @default.
• W2790869523 creator A5088605272 @default.
• W2790869523 creator A5091337793 @default.
• W2790869523 date "2018-03-24" @default.
• W2790869523 modified "2023-10-18" @default.
• W2790869523 title "Outcomes in patients treated with ticagrelor versus clopidogrel after acute myocardial infarction stratified by renal function" @default.
• W2790869523 cites W1891044139 @default.
• W2790869523 cites W1970907468 @default.
• W2790869523 cites W1972679886 @default.
• W2790869523 cites W1978057575 @default.
• W2790869523 cites W2024656127 @default.
• W2790869523 cites W2027607489 @default.
• W2790869523 cites W2038091035 @default.
• W2790869523 cites W2050900880 @default.
• W2790869523 cites W2076605662 @default.
• W2790869523 cites W2085260376 @default.
• W2790869523 cites W2096167354 @default.
• W2790869523 cites W2100377608 @default.
• W2790869523 cites W2119284530 @default.
• W2790869523 cites W2120096427 @default.
• W2790869523 cites W2126009032 @default.
• W2790869523 cites W2128315097 @default.
• W2790869523 cites W2133991213 @default.
• W2790869523 cites W2136796090 @default.
• W2790869523 cites W2140501627 @default.
• W2790869523 cites W2144463115 @default.
• W2790869523 cites W2155634950 @default.
• W2790869523 cites W2155965977 @default.
• W2790869523 cites W2158141377 @default.
• W2790869523 cites W2162756930 @default.
• W2790869523 cites W2166018731 @default.
• W2790869523 cites W2169407681 @default.
• W2790869523 cites W2169772043 @default.
• W2790869523 cites W2270911137 @default.
• W2790869523 cites W2280853297 @default.
• W2790869523 cites W2325918709 @default.
• W2790869523 cites W2490433086 @default.
• W2790869523 cites W2550051895 @default.
• W2790869523 doi "https://doi.org/10.1136/heartjnl-2017-312436" @default.
• W2790869523 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29574413" @default.
• W2790869523 hasPublicationYear "2018" @default.
• W2790869523 type Work @default.
• W2790869523 sameAs 2790869523 @default.
• W2790869523 citedByCount "29" @default.
• W2790869523 countsByYear W27908695232018 @default.
• W2790869523 countsByYear W27908695232019 @default.
• W2790869523 countsByYear W27908695232020 @default.
• W2790869523 countsByYear W27908695232021 @default.
• W2790869523 countsByYear W27908695232022 @default.
• W2790869523 countsByYear W27908695232023 @default.
• W2790869523 crossrefType "journal-article" @default.
• W2790869523 hasAuthorship W2790869523A5000473191 @default.
• W2790869523 hasAuthorship W2790869523A5004123368 @default.
• W2790869523 hasAuthorship W2790869523A5040457003 @default.
• W2790869523 hasAuthorship W2790869523A5043946749 @default.
• W2790869523 hasAuthorship W2790869523A5047500450 @default.
• W2790869523 hasAuthorship W2790869523A5051109511 @default.
• W2790869523 hasAuthorship W2790869523A5073269975 @default.
• W2790869523 hasAuthorship W2790869523A5073596004 @default.
• W2790869523 hasAuthorship W2790869523A5074948512 @default.
• W2790869523 hasAuthorship W2790869523A5088605272 @default.
• W2790869523 hasAuthorship W2790869523A5091337793 @default.
• W2790869523 hasConcept C126322002 @default.
• W2790869523 hasConcept C127413603 @default.
• W2790869523 hasConcept C159641895 @default.
• W2790869523 hasConcept C164705383 @default.
• W2790869523 hasConcept C2777849778 @default.
• W2790869523 hasConcept C2780645631 @default.
• W2790869523 hasConcept C2780890252 @default.
• W2790869523 hasConcept C500558357 @default.
• W2790869523 hasConcept C50382708 @default.
• W2790869523 hasConcept C71924100 @default.
• W2790869523 hasConcept C78519656 @default.
• W2790869523 hasConceptScore W2790869523C126322002 @default.
• W2790869523 hasConceptScore W2790869523C127413603 @default.
• W2790869523 hasConceptScore W2790869523C159641895 @default.
• W2790869523 hasConceptScore W2790869523C164705383 @default.
• W2790869523 hasConceptScore W2790869523C2777849778 @default.
• W2790869523 hasConceptScore W2790869523C2780645631 @default.
• W2790869523 hasConceptScore W2790869523C2780890252 @default.
• W2790869523 hasConceptScore W2790869523C500558357 @default.
• W2790869523 hasConceptScore W2790869523C50382708 @default.
• W2790869523 hasConceptScore W2790869523C71924100 @default.
• W2790869523 hasConceptScore W2790869523C78519656 @default.
• W2790869523 hasFunder F4320320940 @default.
• W2790869523 hasFunder F4320322570 @default.
• W2790869523 hasIssue "19" @default.
• W2790869523 hasLocation W27908695231 @default.

• next